Design-based sampling and quantitation of the respiratory airways

Dallas M. Hyde, Jack R. Harkema, Nancy K. Tyler, Charles Plopper

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Design-based quantitation of the nasal cavity, larynx and tracheobronchial conducting airways after exposure to inhaled toxicants requires complete measurement of all respiratory airways or appropriate sampling followed by morphometric measurements. In vivo imaging (MRI or CT) of the nasal cavity, larynx and conducting airways provides anatomical detail of all the airways down to the distal airways. Since inhaled toxicants show predictable deposition patterns in the airways, identification and sampling of conducting airways becomes essential in a precise toxicological evaluation. Lengths, diameters and luminal surface areas can be directly measured on fixed specimens using a steromicroscope. Estimates of cell numbers, extracellular matrix volumes and vessel/nerve lengths per airway or epithelial basal laminar surface are estimated stereologically. Selected airways are cut into smaller pieces using a "fractionator" for uniform sampling of the airways. Cell numbers are estimated using a "disector." Volumes are estimated using point probes, while length and surface areas are estimated by isotropically oriented sections with plane and line probes; an approach free of assumptions of shape, size or spatial orientation. True biological variance and the average sampling variance of the stereological measurement define the minimal sampling required to achieve precise estimates of the nasal cavity, larynx and conducting airways.

Original languageEnglish (US)
Pages (from-to)286-295
Number of pages10
JournalToxicologic Pathology
Volume34
Issue number3
DOIs
StatePublished - 2006

Fingerprint

Nasal Cavity
Larynx
Sampling
Cell Count
Toxicology
Extracellular Matrix
Magnetic resonance imaging
Imaging techniques

Keywords

  • Disector
  • Fractionator
  • In vivo imaging
  • Larynx and conducting airways
  • Statistical variability
  • Stereology
  • Turbinates

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Design-based sampling and quantitation of the respiratory airways. / Hyde, Dallas M.; Harkema, Jack R.; Tyler, Nancy K.; Plopper, Charles.

In: Toxicologic Pathology, Vol. 34, No. 3, 2006, p. 286-295.

Research output: Contribution to journalArticle

Hyde, Dallas M. ; Harkema, Jack R. ; Tyler, Nancy K. ; Plopper, Charles. / Design-based sampling and quantitation of the respiratory airways. In: Toxicologic Pathology. 2006 ; Vol. 34, No. 3. pp. 286-295.
@article{45cc45fabf3844129b9a21feccb96c2c,
title = "Design-based sampling and quantitation of the respiratory airways",
abstract = "Design-based quantitation of the nasal cavity, larynx and tracheobronchial conducting airways after exposure to inhaled toxicants requires complete measurement of all respiratory airways or appropriate sampling followed by morphometric measurements. In vivo imaging (MRI or CT) of the nasal cavity, larynx and conducting airways provides anatomical detail of all the airways down to the distal airways. Since inhaled toxicants show predictable deposition patterns in the airways, identification and sampling of conducting airways becomes essential in a precise toxicological evaluation. Lengths, diameters and luminal surface areas can be directly measured on fixed specimens using a steromicroscope. Estimates of cell numbers, extracellular matrix volumes and vessel/nerve lengths per airway or epithelial basal laminar surface are estimated stereologically. Selected airways are cut into smaller pieces using a {"}fractionator{"} for uniform sampling of the airways. Cell numbers are estimated using a {"}disector.{"} Volumes are estimated using point probes, while length and surface areas are estimated by isotropically oriented sections with plane and line probes; an approach free of assumptions of shape, size or spatial orientation. True biological variance and the average sampling variance of the stereological measurement define the minimal sampling required to achieve precise estimates of the nasal cavity, larynx and conducting airways.",
keywords = "Disector, Fractionator, In vivo imaging, Larynx and conducting airways, Statistical variability, Stereology, Turbinates",
author = "Hyde, {Dallas M.} and Harkema, {Jack R.} and Tyler, {Nancy K.} and Charles Plopper",
year = "2006",
doi = "10.1080/01926230600713509",
language = "English (US)",
volume = "34",
pages = "286--295",
journal = "Toxicologic Pathology",
issn = "0192-6233",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Design-based sampling and quantitation of the respiratory airways

AU - Hyde, Dallas M.

AU - Harkema, Jack R.

AU - Tyler, Nancy K.

AU - Plopper, Charles

PY - 2006

Y1 - 2006

N2 - Design-based quantitation of the nasal cavity, larynx and tracheobronchial conducting airways after exposure to inhaled toxicants requires complete measurement of all respiratory airways or appropriate sampling followed by morphometric measurements. In vivo imaging (MRI or CT) of the nasal cavity, larynx and conducting airways provides anatomical detail of all the airways down to the distal airways. Since inhaled toxicants show predictable deposition patterns in the airways, identification and sampling of conducting airways becomes essential in a precise toxicological evaluation. Lengths, diameters and luminal surface areas can be directly measured on fixed specimens using a steromicroscope. Estimates of cell numbers, extracellular matrix volumes and vessel/nerve lengths per airway or epithelial basal laminar surface are estimated stereologically. Selected airways are cut into smaller pieces using a "fractionator" for uniform sampling of the airways. Cell numbers are estimated using a "disector." Volumes are estimated using point probes, while length and surface areas are estimated by isotropically oriented sections with plane and line probes; an approach free of assumptions of shape, size or spatial orientation. True biological variance and the average sampling variance of the stereological measurement define the minimal sampling required to achieve precise estimates of the nasal cavity, larynx and conducting airways.

AB - Design-based quantitation of the nasal cavity, larynx and tracheobronchial conducting airways after exposure to inhaled toxicants requires complete measurement of all respiratory airways or appropriate sampling followed by morphometric measurements. In vivo imaging (MRI or CT) of the nasal cavity, larynx and conducting airways provides anatomical detail of all the airways down to the distal airways. Since inhaled toxicants show predictable deposition patterns in the airways, identification and sampling of conducting airways becomes essential in a precise toxicological evaluation. Lengths, diameters and luminal surface areas can be directly measured on fixed specimens using a steromicroscope. Estimates of cell numbers, extracellular matrix volumes and vessel/nerve lengths per airway or epithelial basal laminar surface are estimated stereologically. Selected airways are cut into smaller pieces using a "fractionator" for uniform sampling of the airways. Cell numbers are estimated using a "disector." Volumes are estimated using point probes, while length and surface areas are estimated by isotropically oriented sections with plane and line probes; an approach free of assumptions of shape, size or spatial orientation. True biological variance and the average sampling variance of the stereological measurement define the minimal sampling required to achieve precise estimates of the nasal cavity, larynx and conducting airways.

KW - Disector

KW - Fractionator

KW - In vivo imaging

KW - Larynx and conducting airways

KW - Statistical variability

KW - Stereology

KW - Turbinates

UR - http://www.scopus.com/inward/record.url?scp=33646816738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646816738&partnerID=8YFLogxK

U2 - 10.1080/01926230600713509

DO - 10.1080/01926230600713509

M3 - Article

C2 - 16698728

AN - SCOPUS:33646816738

VL - 34

SP - 286

EP - 295

JO - Toxicologic Pathology

JF - Toxicologic Pathology

SN - 0192-6233

IS - 3

ER -